WO2014173046A1 - Système de guidage adaptatif pour la chirurgie d'obturation de défaut septal auriculaire percutané à l'aide d'un guide unique d'échocardiographie transthoracique - Google Patents
Système de guidage adaptatif pour la chirurgie d'obturation de défaut septal auriculaire percutané à l'aide d'un guide unique d'échocardiographie transthoracique Download PDFInfo
- Publication number
- WO2014173046A1 WO2014173046A1 PCT/CN2013/081669 CN2013081669W WO2014173046A1 WO 2014173046 A1 WO2014173046 A1 WO 2014173046A1 CN 2013081669 W CN2013081669 W CN 2013081669W WO 2014173046 A1 WO2014173046 A1 WO 2014173046A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- catheter
- guide wire
- ultrasound
- septal defect
- sheath
- Prior art date
Links
- 208000035478 Interatrial communication Diseases 0.000 title claims abstract description 70
- 208000013914 atrial heart septal defect Diseases 0.000 title claims abstract description 70
- 206010003664 atrial septal defect Diseases 0.000 title claims abstract description 70
- 230000003044 adaptive effect Effects 0.000 title claims abstract description 7
- 238000001356 surgical procedure Methods 0.000 title claims description 18
- 238000010967 transthoracic echocardiography Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 24
- 238000011282 treatment Methods 0.000 claims abstract description 12
- 238000005452 bending Methods 0.000 claims abstract description 9
- 229910000831 Steel Inorganic materials 0.000 claims abstract description 4
- 239000010959 steel Substances 0.000 claims abstract description 4
- 229910001000 nickel titanium Inorganic materials 0.000 claims abstract description 3
- 238000002604 ultrasonography Methods 0.000 claims description 101
- 210000003191 femoral vein Anatomy 0.000 claims description 35
- 210000005246 left atrium Anatomy 0.000 claims description 27
- 238000003780 insertion Methods 0.000 claims description 23
- 230000037431 insertion Effects 0.000 claims description 23
- 208000025339 heart septal defect Diseases 0.000 claims description 12
- 230000003902 lesion Effects 0.000 claims description 9
- 238000002627 tracheal intubation Methods 0.000 claims description 9
- 206010002091 Anaesthesia Diseases 0.000 claims description 8
- 230000037005 anaesthesia Effects 0.000 claims description 8
- 230000023597 hemostasis Effects 0.000 claims description 8
- 210000005245 right atrium Anatomy 0.000 claims description 8
- 238000011976 chest X-ray Methods 0.000 claims description 7
- 210000003748 coronary sinus Anatomy 0.000 claims description 7
- 230000003601 intercostal effect Effects 0.000 claims description 7
- 210000001562 sternum Anatomy 0.000 claims description 7
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims description 6
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 claims description 6
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 claims description 6
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 6
- 229960001138 acetylsalicylic acid Drugs 0.000 claims description 6
- 230000010100 anticoagulation Effects 0.000 claims description 6
- 210000004013 groin Anatomy 0.000 claims description 6
- 229960002725 isoflurane Drugs 0.000 claims description 6
- 229960003299 ketamine Drugs 0.000 claims description 6
- 229960004194 lidocaine Drugs 0.000 claims description 6
- 238000002690 local anesthesia Methods 0.000 claims description 6
- 239000003055 low molecular weight heparin Substances 0.000 claims description 6
- 229940127215 low-molecular weight heparin Drugs 0.000 claims description 6
- 230000000740 bleeding effect Effects 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 210000004115 mitral valve Anatomy 0.000 claims description 4
- 210000001631 vena cava inferior Anatomy 0.000 claims description 4
- 210000000709 aorta Anatomy 0.000 claims description 3
- 230000007547 defect Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 210000000591 tricuspid valve Anatomy 0.000 claims description 3
- 230000006835 compression Effects 0.000 claims 4
- 238000007906 compression Methods 0.000 claims 4
- 206010067171 Regurgitation Diseases 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- 238000007920 subcutaneous administration Methods 0.000 claims 2
- 230000002792 vascular Effects 0.000 claims 2
- 230000001746 atrial effect Effects 0.000 claims 1
- 230000002440 hepatic effect Effects 0.000 claims 1
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 abstract 1
- 230000005855 radiation Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 238000007789 sealing Methods 0.000 description 5
- 206010058039 Cardiac perforation Diseases 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000005259 peripheral blood Anatomy 0.000 description 4
- 239000011886 peripheral blood Substances 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 208000006017 Cardiac Tamponade Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 208000002330 Congenital Heart Defects Diseases 0.000 description 3
- 206010027727 Mitral valve incompetence Diseases 0.000 description 3
- 206010040744 Sinus headache Diseases 0.000 description 3
- 201000001943 Tricuspid Valve Insufficiency Diseases 0.000 description 3
- 206010044640 Tricuspid valve incompetence Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 208000028831 congenital heart disease Diseases 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000002837 heart atrium Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010003226 Arteriovenous fistula Diseases 0.000 description 1
- 206010048761 Atrial rupture Diseases 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 210000003157 atrial septum Anatomy 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002458 fetal heart Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000009067 heart development Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0097—Catheters; Hollow probes characterised by the hub
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
- A61M2025/09175—Guide wires having specific characteristics at the distal tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0041—Catheters; Hollow probes characterised by the form of the tubing pre-formed, e.g. specially adapted to fit with the anatomy of body channels
Definitions
- the present invention belongs to the field of medical technology, and particularly relates to a percutaneous transluminal septal defect sealing method and an adaptive guiding system thereof. Background technique
- Atrial septal defect which is one of the most common types of congenital heart disease, is formed by residual defects in the atrial septum during embryonic development. Most of the septal defects are single-hole type, a few are porous, and very few are mesh-shaped. The gap between the rooms and the congenital heart disease is about 15%-20%, and the ratio of male to female is 1.7:1.
- Open-chest surgery is the earliest method. It is suitable for all types of patients and saves a lot of patients' lives. However, it has shortcomings such as long surgical incision, need for extracorporeal circulation, long recovery time, and psychological and physical trauma to patients. They are very large. In order to overcome these shortcomings, there is a occlusion of percutaneous atrial septal defect, which has the advantages of small trauma and quick recovery after surgery. However, patients must be irradiated with radiation during surgery. Radiation damage may affect the organs such as bone marrow, genitals and thyroid.
- the contrast agent used in the operation has risks such as allergies and renal failure; if life-threatening complications such as occluder detachment, cardiac perforation, and pericardial tamponade occur during the operation, emergency transfer to the surgical room is required for thoracic rescue, translocation. Time is it The key to saving the lives of patients.
- the present invention provides a simple transthoracic ultrasound guided percutaneous intervention for atrial septal defect closure.
- An adapted guidance system for said transthoracic ultrasound guided percutaneous interventional atrial septal defect occlusion is provided.
- the present invention provides a novel guiding system for occlusion of a percutaneous transluminal septal defect guided by a simple transthoracic ultrasound, the guiding system comprising a catheter for adjusting the direction and controlling the diameter of the guide wire head, for facilitating ultrasound display and passage A guide wire that is missing from the room and a loading sheath that feeds the guide wire into the catheter.
- the guide wire is divided into two parts: a guide wire body and a head portion of an integrally formed structure, the main body portion is made of 0.035 inch steel wire, and the head is in a spindle-shaped three-dimensional structure, which is woven by a high elastic nickel-titanium alloy wire. a rivet at the end of the head, the rivet having a hemispherical shape and a smooth surface;
- the catheter is a hollow catheter suitable for inserting and smoothly sliding the guide wire, and is divided into a head and a tail according to an insertion direction of the guide wire inserted therein, and the head and the tail are respectively provided with holes for insertion of a guide wire
- the duct includes a curved section near the head position and a straight section of the remaining portion, the curved section and the straight section are smoothly bent; the tail end of the duct is provided with a spiral Interface for connecting the loading sheath or hemostasis;
- the loading sheath is a hollow tubular structure, and the loading sheath is provided with symmetric wing-shaped protrusions at the outer wall, the wing protrusions being disposed at a position close to the loading sheath inserted into the conduit for inserting the Fixation is achieved in the interface at the tail of the catheter.
- the guide wire has a total length of 115-125 cm, the main body portion of the guide wire has a length of 110-124 cm, the head length is 1-5 cm, and the spindle structure of the head is at the widest point. 1-3 cm;
- the length of the conduit is 70-80 cm, wherein the curved section is 2-8 cm long, the length of the remaining straight section is 62-78 cm, and the bending angle of the curved section and the straight section is 130- 140° ;
- the loading sheath has a total length of 6-10 cm, and the wing protrusion is disposed at a position 1.5 to 2.5 cm near the direction in which the loading sheath is inserted into the catheter.
- the guide wire has a total length of 120 cm
- the main body portion of the guide wire has a length of 118 cm
- the head has a length of 2 cm
- the spindle structure of the head has a width of 1 cm at the widest point.
- the length of the conduit is 75 cm, wherein the curved section is 5 cm long, the length of the remaining straight section is 70 cm, and the bending angle of the curved section and the straight section is 135°;
- the full length is 8 cm, and the wing-like projection is disposed at a position 2 cm away from the direction in which the loading sheath is inserted into the catheter.
- the points on the outer wall of the straight section of the catheter are marked with an order every 1 cm to record the depth of the catheter into the body.
- the catheter and the loading sheath are divided into two models, 5F and 6F, according to the inner diameter.
- the method for sealing the percutaneous atrial septal defect guided by the simple transthoracic ultrasound according to the present invention is a single guiding method using ultrasound, using a guiding system or an existing interventional device.
- the invention also discloses a simple transthoracic ultrasound guided percutaneous transluminal septal defect occlusion using the guiding system described above, which specifically comprises:
- the guide wire is pushed forward until the guide wire head reaches the tip of the catheter, but the guide wire does not extend out of the catheter, and the catheter loaded with the guide wire is delivered into the patient through the arterial sheath.
- Ultrasound detection reveals that the catheter reaches the heart. Or after the catheter insertion depth reaches the aforementioned optimal working distance, the guide wire is pushed forward, the head of the guide wire is extended out of the catheter, and the opening is in a spindle shape. Due to the increased volume, the ultrasound can clearly and conveniently detect the guide wire.
- the catheter guidewire under ultrasound guidance, operating the catheter guidewire, through the atrial septal defect, if the diameter of the atrial septal defect is smaller, the diameter is smaller than the widest diameter of the spindle-shaped head of the guidewire, the first half of the spindle-shaped head of the guidewire can be
- the guide wire is fixed, the catheter is pushed forward, the posterior portion of the spindle-shaped head is retracted into the catheter, the volume of the guide wire is reduced, and the catheter and the guide wire are pushed forward together.
- the catheter can pass through the lesion; after the catheter passes through the atrial septal defect, exit the catheter and the arterial sheath, and keep the guide wire in the left atrium; according to the diameter of the occluder, select 8 ⁇ 10F of traditional atrial septal defect closure
- the sheath is sent to the left atrium along the guide wire, and after exiting the guide wire and the inner core, it is sent to the atrial septal defect occluder and sealed under ultrasonic monitoring; after the occluder is successfully placed, the ultrasound is carefully checked for residual shunt.
- the mitral valve, the tricuspid valve have no reflux, and the coronary sinus has no pressure. Confirm the position and shape of the occluder. After the occlusion is successful, turn the delivery rod counterclockwise to release the occluder.
- the long sheath is routinely pulled out and pressed to stop bleeding, and the bandage is bandaged.
- the method further includes:
- the invention also discloses a simple transthoracic ultrasound guided percutaneous transluminal septal defect occlusion using a multi-functional catheter and a guide wire in the prior art, comprising the following steps:
- peripheral blood vessel ultrasound should be performed to confirm whether the guide wire is located in the femoral vein; If it is not in the femoral vein, or if the ultrasound is unclear, the skin should be cut open, and the femoral canal should be placed after the free femoral vein.
- the catheter When the ultrasound upper catheter image disappears, the catheter is pushed forward slightly to display the catheter tip, and the catheter tip is operated through the chamber under ultrasound guidance.
- Septal defect After the catheter passes through the atrial septal defect, insert the super-hard guide wire into the left atrium, exit the catheter and the arterial sheath; according to the diameter of the occluder, select the traditional atrial septal defect occlusion sheath of 8 ⁇ 10F, along the
- the super-hard guide wire is sent to the left atrium, and the left atrium is repeatedly scanned by ultrasound to show the tip end of the delivery sheath, which cannot be inserted too deeply; if the delivery sheath is inserted After the guide wire and the inner core are withdrawn, the delivery sheath will be dislodged into the right atrium, and the above steps need to be repeated; after the delivery sheath is sent to the left atrium, it is sent to the atrial septal defect occluder through the delivery sheath, and is performed under ultrasonic testing.
- the ultrasound was carefully examined for residual shunt, mitral and tricuspid regurgitation, and coronary sinus pressure. Confirm the position and shape of the occluder. After the occlusion is successful, turn the delivery rod counterclockwise to release the occluder. The long sheath is routinely pulled out and pressed to stop bleeding, and the bandage is bandaged.
- the method further includes:
- the indications and prohibition of the percutaneous transluminal septal defect in the simple transthoracic ultrasound guided by the present invention The symptoms include:
- Indications Age 2 years; body weight 10 kg, atrial septal defect with a 5 mm diameter and a right heart volume load; the distance from the margin of the defect to the coronary sinus, superior and inferior vena cava, and pulmonary veins is 5 ⁇ , The distance to the atrioventricular valve is 7 mm; the diameter of the septum is selected > the diameter of the left atrium side of the occluder selected. Contraindications: primary hole and sinus atrial septal defect; endocarditis and hemorrhagic disease; thrombus in the place of occluder, venous thrombosis at the catheter insertion; severe pulmonary hypertension leading to right-to-left shunt, Combine diseases that require surgical treatment.
- the simple transthoracic ultrasound-guided percutaneous atrial septal defect sealing method utilizes ultrasound as the sole guiding medium, which not only overcomes the problem of radiation and contrast agent damage caused by radiation as a guiding medium in the prior art, and truly does not Open, non-radiative, non-contrast agent for atrial septal defect; if the puncture is difficult, or if the guide wire is located in the femoral vein, the surgeon can open the skin, free the femoral vein, and insert the arterial sheath; and once the closure fails or appears When life-threatening complications such as occluder shedding, cardiac perforation, and pericardial tamponade, the surgeon can immediately open the chest for open heart surgery to maximize patient safety.
- This technology can be completed in a general surgical operating room, eliminating the need for expensive large-scale radiation equipment and facilitating widespread application.
- the technique does not require endotracheal intubation, and patients who are treated with the treatment can perform the operation under local anesthesia. Children who do not cooperate with the treatment can complete the operation under basic anesthesia;
- the present invention discloses a simple transthoracic ultrasound guided percutaneous transluminal septal defect occlusion that can be achieved by using a conventional multi-functional catheter, although the method requires more attention during the operation, especially Need to repeat the ultrasound to judge, the surgeon's technology and experience have certain requirements, but it can still overcome the radiation and contrast agent damage caused by the ray-guided occlusion technique in the prior art, and has high safety guarantee. ;
- the novel guiding system of the present invention is designed as an open spindle-shaped three-dimensional structure due to the insertion portion of the guide wire, due to the volume. Increase, ultrasound can clearly and conveniently explore the AC segment.
- the AB segment can be sent to the lesion, the guide wire is fixed, the catheter is pushed forward, and the BC segment or even part of the AB segment is retracted into the catheter, catheter and guide.
- the silk is pushed forward together, the ultrasound can be accurately guided through the atrial septal defect;
- FIG. 2 is a schematic structural view of a catheter in the guiding system of the present invention.
- the guiding system of the present invention includes a catheter for adjusting the direction and controlling the diameter of the guidewire head, a guidewire for facilitating ultrasound display and passage through the atrium, and a loading sheath for feeding the guidewire into the catheter.
- the guide wire is divided into a main body of the guide wire and a head portion of the integrally formed structure, and has a total length of 115 to 125 cm, and preferably 120 cm.
- the main body portion (CD segment) of the guide wire is made of 0.035 inch steel wire and has a length of 110-124 cm, and preferably 118 cm;
- the head (AC segment) has a spindle-shaped three-dimensional structure, and is made of high elasticity nickel.
- a telescoping structure woven from a titanium alloy wire having a length of 1-5 cm, and preferably 2 cm, the widest part (BE segment) of the spindle-shaped structure of the head being 1-3 cm, and preferably 1
- the centimeter is provided with a rivet at the end point (point A) of the head, the rivet being hemispherical and having a smooth surface.
- the catheter is a hollow catheter suitable for inserting and smoothly sliding the guide wire, and is divided into a head and a tail according to a direction in which the guide wire inserted therein is inserted, and the head and the tail are respectively
- a hole is provided for insertion and insertion of the guide wire, and the catheter is conventionally divided into two models of 5F and 6F according to the inner diameter.
- the duct includes a curved section (FG section) near the head position and a straight section (GH section) of the remaining portion, and the bending section and the straight section have a bending angle of 130-140° and preferably 135 °, the total length of the conduit is 70-80 cm, and preferably 75 cm, wherein the curved section is 2-8 cm long, and preferably 5 cm, and the remaining straight section has a length of 62-78 cm, and preferably 70 cm.
- the catheter's tail end is provided with a screw interface for attaching the loading sheath or hemostasis.
- the points on the outer wall of the straight section of the catheter are marked with Arabic numerals every 1 cm in order to mark the depth of the catheter into the body.
- the loading sheath is a hollow tubular structure, which is conventionally divided into two models according to the inner diameter of 5F and 6F.
- the loading sheath is provided with symmetrical wing-like protrusions at the outer wall for facilitating the fixing sheath Tube and catheter.
- the loading sheath has a total length of 6-10 cm, and preferably 8 cm (IK segment), and the wing protrusion is disposed at a position 1.5 to 2.5 cm and preferably 2 cm near the direction in which the loading sheath is inserted into the catheter (IJ segment) ), for inserting into the interface at the tail of the catheter to achieve fixation.
- the distance from the third intercostal space of the patient's sternum to the ipsilateral femoral vein puncture point is measured first, which is the optimal working distance of the system.
- the head of the guide wire, that is, the AC segment, is loaded into the sheath, and the IJ segment of the loading sheath is inserted into the tail of the catheter.
- the guide wire is pushed forward until point A reaches point F, ie the guide wire head reaches the tip of the catheter, but the guide wire does not extend out of the catheter.
- the catheter loaded with the guide wire is delivered into the patient through the arterial sheath.
- the guide wire is pushed forward, and the AC segment is extended out of the catheter, AC.
- the opening is in the shape of a spindle. Due to the increased volume, the ultrasound can clearly and conveniently probe the AC segment. Under ultrasound guidance, the catheter guidewire is manipulated through the lesion.
- the AB segment can be sent over the lesion, the guide wire is fixed, the catheter is pushed forward, and the BC segment or even part of the AB segment is retracted into the catheter.
- the guide wires are pushed forward together to pass through the atrial septal defect.
- the new guiding system can exit the guide wire (AD) after passing through the atrial septal defect, insert a 0.035 super-hard guide wire along the catheter (FH), exit the catheter (FH), and insert the atrial septal defect along the super-hard guide wire.
- the delivery sheath of the device is sent to the occluder along the sheath for occlusion treatment.
- the novel guiding system for occluding the percutaneous transluminal septal defect guided by simple transthoracic ultrasound includes a catheter for adjusting the direction and controlling the diameter of the guide wire head, facilitating the ultrasound display and passing through the room. The missing guide wire and the loading sheath that feeds the guide wire into the catheter.
- the guide wire has a total length of 120 cm, wherein the main body portion has a length of 118 cm and a head portion of 2 cm, and has a spindle-shaped three-dimensional structure and a maximum width of 1 cm, and is provided at the end point (point A) of the head portion.
- rivets which are hemispherical and have a smooth surface.
- the catheter has a total length of 75 cm and includes a curved section 5 cm long near the head position. And the remaining portion of the straight section is 70 cm long, and the bending angle of the curved section and the straight section is 135 °.
- the tail end of the catheter is provided with a screw interface for connecting the loading sheath or the hemostasis.
- the points on the outer wall of the straight section of the catheter are marked with Arabic numerals every 1 cm order to facilitate marking the depth of the catheter into the body.
- the loading sheath is a hollow tubular structure, and symmetric wing-shaped protrusions are arranged at the outer wall to facilitate fixing the sheath tube and the catheter.
- the loading sheath has a total length of 8 cm, and the wing-like projection is disposed at a position 2 cm from the direction in which the loading sheath is inserted into the catheter for insertion into the joint at the tail of the catheter to achieve fixation.
- the novel guiding system for occluding the percutaneous transluminal septal defect guided by simple transthoracic ultrasound includes a catheter for adjusting the direction and controlling the diameter of the guide wire head, facilitating the ultrasound display and passing through the room. The missing guide wire and the loading sheath that feeds the guide wire into the catheter.
- the guide wire has a total length of 115 cm, wherein the main body portion is 110 cm long and the head is 5 cm long, and has a spindle-shaped three-dimensional structure and a maximum width of 3 cm at the end point (point A) of the head. Rivets are provided, the rivets being hemispherical and having a smooth surface.
- the full length of the catheter was 70 cm, including a curved section 8 cm long near the head position, and the remaining straight section was 62 cm long, and the curved section and the straight section were bent at an angle of 130°.
- the tail end of the catheter is provided with a screw interface for connecting the loading sheath or the hemostasis.
- the points on the outer wall of the straight section of the catheter are marked with Arabic numerals every 1 cm in order to mark the depth of the catheter into the body.
- the loading sheath is a hollow tubular structure, and symmetric wing-shaped protrusions are arranged at the outer wall to facilitate fixing the sheath tube and the catheter.
- the loading sheath has a total length of 6 cm, and the wing-like projection is disposed at a position 1.5 cm away from the direction in which the loading sheath is inserted into the catheter for insertion into the interface at the tail of the catheter for fixation.
- the novel guiding system includes a catheter for adjusting the direction and controlling the diameter of the guidewire head, a guidewire for facilitating ultrasound display and passage through the atrium, and a loading sheath for feeding the guidewire into the catheter.
- the guide wire has a total length of 125 cm, wherein the main body portion is 124 cm long and the head is 1 cm long, and has a spindle-shaped three-dimensional structure and a maximum width of 2 cm at the end point (point A) of the head. Rivets are provided, the rivets being hemispherical and having a smooth surface.
- the full length of the catheter was 80 cm, including a curved section 2 cm long near the head position, and the remaining straight section was 78 cm long, and the curved section and the straight section were bent at an angle of 140 °.
- the tail end of the catheter is provided with a screw interface for connecting the loading sheath or the hemostasis.
- the points on the outer wall of the straight section of the catheter are marked with Arabic numerals every 1 cm in order to mark the depth of the catheter into the body.
- the loading sheath is a hollow tubular structure, and symmetric wing-shaped protrusions are arranged at the outer wall to facilitate fixing the sheath tube and the catheter.
- the loading sheath has a total length of 10 cm, and the wing-like projection is disposed at a position 2.5 cm from the direction in which the loading sheath is inserted into the catheter for insertion into the interface at the tail of the catheter to achieve fixation.
- the method for sealing the percutaneous atrial septal defect guided by the simple transthoracic ultrasound according to the present invention is a single guiding method using ultrasound, using a guiding system or an existing interventional device.
- the simple transthoracic ultrasound guided percutaneous transluminal septal occlusion is performed by the guiding system in the first embodiment, and the specific steps include:
- the distance from the third intercostal space of the patient's sternum to the puncture point of the femoral vein is measured, which is the optimal working distance of the guiding system.
- the guidewire guidewire is loaded into the sheath, the guidewire is advanced into the catheter through the loading sheath, and the guidewire is pushed forward until the guidewire head reaches the catheter tip, but the guidewire does not extend out of the catheter.
- the catheter loaded with the guide wire is delivered into the patient through the arterial sheath. After the ultrasonic examination detects that the catheter reaches the heart, or after the catheter insertion depth reaches the optimal working distance, the guide wire is pushed forward to extend the head of the guide wire.
- the catheter is opened and has a spindle shape. Due to the increased volume, the ultrasound can clearly and conveniently probe the head of the guide wire. Under ultrasound guidance, the catheter guidewire is operated through the atrial septal defect. If the diameter of the atrial septal defect is smaller and the diameter is smaller than the widest diameter (1 cm) of the spindle-shaped head of the guide wire, the first half of the spindle-shaped head of the guide wire can be sent through the atrial septal defect, the guide wire is fixed, and the catheter is oriented. Before the push, the rear portion of the guide wire spindle-shaped head is retracted into the catheter, and the guide wire head is reduced in volume, and the catheter and the guide wire are pushed forward together to pass through the lesion.
- the catheter and the arterial sheath are withdrawn, and the guide wire is located in the left atrium. Since the guide wire is spindle-shaped and large in volume, the ultrasound can clearly show the depth of insertion of the guide wire into the left atrium.
- the silk head has a large surface area, it is not easy to break the left atrium wall, and it is not easy to get out of the atrial septal defect into the right atrium.
- the traditional atrial septal defect occlusion sheath of 8 ⁇ 10F is selected, sent along the guide wire to the left atrium, the guide wire and the inner core are withdrawn, and the atrial septal defect occluder is sent to the ultrasound. Blocking under monitoring;
- the ultrasound was carefully examined for residual shunt, mitral and tricuspid regurgitation, and coronary sinus pressure. Confirm the position and shape of the occluder. After the occlusion is successful, turn the delivery rod counterclockwise to release the occluder. Routinely pull out the long sheath and compress the hemostasis, and bandage the pressure bandage;
- Example 5 The simple transthoracic ultrasound guided percutaneous transluminal septal occlusion is performed by a multi-functional catheter guiding system used in conventional ray guiding in the prior art, and the specific steps include:
- the ultrasound can not accurately display the catheter guide.
- the position of the silk head after the catheter is delivered into the body to reach the marked point, the ultrasound shows the inferior vena cava liver segment.
- the catheter is pushed forward slightly, and the ultrasound is displayed in a four-chamber heart or a short axis of the aorta.
- the septal defect, the guide wire is removed, and the multi-functional catheter is rotated.
- the catheter image appears on the ultrasound image, the fixed catheter stops rotating, and the catheter is slowly withdrawn.
- the catheter When the ultrasound upper catheter image disappears, the catheter is pushed forward to display the catheter. At the head end, the catheter tip is operated through the atrial septal defect under ultrasound guidance. After the catheter passes through the atrial septal defect, a super-hard guide wire is inserted into the left atrium, and the catheter and the arterial sheath are withdrawn. This step requires great care. Because the ultrasound scans with the cut surface, it is difficult to show the depth of the super-hard guide wire inserted into the left atrium. It is inserted too deeply, and it is easy to cause the left atrial perforation, rupture or guide wire to enter the left ventricle, and damage the mitral valve. The insertion is too shallow, the guide wire is easy to get out of the room when the sheath is delivered.
- the ultrasound should repeatedly scan the left atrium to determine the depth of insertion of the superhard guide wire.
- 8 ⁇ 10F of the traditional atrial septal defect occlusion sheath is delivered to the left atrium along the super-hard guide wire. This process also requires great care. It is difficult to show the delivery sheath inserted into the left atrium due to ultrasound. The depth of the delivery sheath is hard. If the insertion is too deep, it is easy to pierce the left atrium wall. Therefore, the ultrasound should repeatedly scan the left atrium to show the delivery sheath. The head end can't be inserted too deep.
- the ultrasound needs to repeatedly scan the left atrium to show the insertion position of the delivery sheath tip end. After the delivery sheath is sent to the left atrium, it is sent to the atrial septal defect occluder through the delivery sheath, and is sealed under ultrasonic detection;
- the ultrasound was carefully examined for residual shunt, mitral and tricuspid regurgitation, and coronary sinus pressure. Confirm the position and shape of the occluder. After the occlusion is successful, turn the delivery rod counterclockwise to release the occluder. Routinely pull out the long sheath and compress the hemostasis, and bandage the pressure bandage;
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201380075968.4A CN105188824B (zh) | 2013-04-25 | 2013-08-16 | 一种用于单纯经胸超声引导下经皮房间隔缺损封堵术的适配引导系统 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201320214475.1 | 2013-04-25 | ||
CN2013202144751U CN203169800U (zh) | 2013-04-25 | 2013-04-25 | 一种治疗引导装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014173046A1 true WO2014173046A1 (fr) | 2014-10-30 |
Family
ID=49066557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/081669 WO2014173046A1 (fr) | 2013-04-25 | 2013-08-16 | Système de guidage adaptatif pour la chirurgie d'obturation de défaut septal auriculaire percutané à l'aide d'un guide unique d'échocardiographie transthoracique |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN203169800U (fr) |
WO (1) | WO2014173046A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11400257B2 (en) | 2017-11-13 | 2022-08-02 | Teleflex Life Sciences Pte. Ltd. | Frictionless catheter |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105339034B (zh) * | 2013-09-30 | 2018-12-18 | 潘湘斌 | 一种用于超声引导下室间隔缺损封堵术的适配引导系统 |
CN108523940A (zh) * | 2017-03-02 | 2018-09-14 | 潘湘斌 | 一种用于超声引导经皮介入治疗的抓捕器 |
CN111513773B (zh) * | 2020-03-30 | 2022-01-14 | 北京大学深圳研究生院 | 可回收的心室隔离装置、回收装置及系统 |
CN111481272B (zh) * | 2020-05-14 | 2022-04-12 | 北京大学第三医院(北京大学第三临床医学院) | 超声引导下穿刺定位引导线及其制作方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040220610A1 (en) * | 1999-11-08 | 2004-11-04 | Kreidler Marc S. | Thin film composite lamination |
CN101849862A (zh) * | 2010-05-12 | 2010-10-06 | 李红昕 | 用于经胸微创封堵室间隔缺损术的探条输送系统 |
CN201814606U (zh) * | 2010-09-30 | 2011-05-04 | 周沂林 | 一种封堵器介入输送装置 |
US20120016409A1 (en) * | 2010-04-29 | 2012-01-19 | Danny Azriel Sherwinter | Systems and methods for facilitating closure of bodily openings |
CN102743207A (zh) * | 2011-04-20 | 2012-10-24 | 首都医科大学宣武医院 | 血栓破碎取栓器 |
-
2013
- 2013-04-25 CN CN2013202144751U patent/CN203169800U/zh not_active Expired - Lifetime
- 2013-08-16 WO PCT/CN2013/081669 patent/WO2014173046A1/fr active Application Filing
- 2013-08-16 CN CN201380075968.4A patent/CN105188824B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040220610A1 (en) * | 1999-11-08 | 2004-11-04 | Kreidler Marc S. | Thin film composite lamination |
US20120016409A1 (en) * | 2010-04-29 | 2012-01-19 | Danny Azriel Sherwinter | Systems and methods for facilitating closure of bodily openings |
CN101849862A (zh) * | 2010-05-12 | 2010-10-06 | 李红昕 | 用于经胸微创封堵室间隔缺损术的探条输送系统 |
CN201814606U (zh) * | 2010-09-30 | 2011-05-04 | 周沂林 | 一种封堵器介入输送装置 |
CN102743207A (zh) * | 2011-04-20 | 2012-10-24 | 首都医科大学宣武医院 | 血栓破碎取栓器 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11400257B2 (en) | 2017-11-13 | 2022-08-02 | Teleflex Life Sciences Pte. Ltd. | Frictionless catheter |
Also Published As
Publication number | Publication date |
---|---|
CN105188824A (zh) | 2015-12-23 |
CN203169800U (zh) | 2013-09-04 |
CN105188824B (zh) | 2018-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102367877B1 (ko) | 판막 클램핑 장치 | |
WO2014173046A1 (fr) | Système de guidage adaptatif pour la chirurgie d'obturation de défaut septal auriculaire percutané à l'aide d'un guide unique d'échocardiographie transthoracique | |
Huang et al. | A comparative study of perventricular and percutaneous device closure treatments for isolated ventricular septal defect: a Chinese single-institution experience | |
CN115777629A (zh) | 一种心肌缺血再灌注模型的建立和评价方法 | |
BAMFORTH | complications during endotracheaI anesthesia | |
Zhang et al. | Treatment of perimembranous ventricular septal defect in children weighing less than 15 kg: minimally invasive periventricular device occlusion versus right subaxillary small incision surgical repair | |
US11083492B2 (en) | Method for implanting an interventional medical device | |
EP4382159A1 (fr) | Mécanisme de détachement et cathéter d'administration | |
CN217907855U (zh) | 一种用于使组织闭合的装置 | |
CN110876633B (zh) | 一种可降解封堵器的专用输送器 | |
Backer | Ventricular septal defect | |
Charan Reddy et al. | Diagnosis and management of a rare case of ruptured sinus of Valsalva into the right atrium | |
He et al. | Surgical repair of complex aortopulmonary window: a case study | |
Lock et al. | Catheter intervention: septostomy, occlusion techniques, and pericardial drainage | |
Boesen et al. | The diagnosis of congenital heart disease in infants by catheterization and selective angiocardiography | |
CN111265259A (zh) | 一种超声心动图引导下成人先天性心脏病介入治疗用装置 | |
WO2015042938A1 (fr) | Système de guidage adaptatif pour occlusion de communication interventriculaire sous guidage ultrasonore | |
McGARRY et al. | Congenital fistula between left ventricle and coronary sinus. | |
Pan et al. | Percutaneous and non-fluoroscopical (PAN) procedure for structural heart disease | |
RAO | Transposition of the great arteries | |
Liu et al. | Exploration to the Application of Hybird Technology in Special Types of Congenital Heart Diseases in Children | |
Hu et al. | Asymmetric Occluder Occlusion of Outlet Ventricular Septal Defect Via a Subaxillary Approach | |
Huang et al. | Transcatheter ventricular septal defect closure via femoral vein alone under transthoracic echocardiography guidance without fluoroscopy: preliminary experience | |
Velasco et al. | LAA Occlusion Technique and Challenging Scenarios | |
RIMENSBERGER et al. | Pulmonary artery catheter placement under transoesophageal echocardiography guidance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201380075968.4 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13882947 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 26.02.2016) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13882947 Country of ref document: EP Kind code of ref document: A1 |